PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 234 filers reported holding PDL BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $8,000 | -11.1% | 2,800 | 0.0% | 0.00% | – |
Q3 2017 | $9,000 | +28.6% | 2,800 | 0.0% | 0.00% | – |
Q2 2017 | $7,000 | +16.7% | 2,800 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
Q4 2016 | $6,000 | -33.3% | 2,800 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
Q2 2016 | $9,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
Q1 2016 | $9,000 | -10.0% | 2,800 | 0.0% | 0.00% | – |
Q4 2015 | $10,000 | -28.6% | 2,800 | 0.0% | 0.00% | – |
Q3 2015 | $14,000 | -22.2% | 2,800 | 0.0% | 0.00% | – |
Q2 2015 | $18,000 | -10.0% | 2,800 | 0.0% | 0.00% | – |
Q1 2015 | $20,000 | -9.1% | 2,800 | 0.0% | 0.00% | – |
Q4 2014 | $22,000 | +4.8% | 2,800 | 0.0% | 0.00% | – |
Q3 2014 | $21,000 | -22.2% | 2,800 | 0.0% | 0.00% | – |
Q2 2014 | $27,000 | +17.4% | 2,800 | 0.0% | 0.00% | – |
Q1 2014 | $23,000 | -4.2% | 2,800 | 0.0% | 0.00% | – |
Q4 2013 | $24,000 | +9.1% | 2,800 | 0.0% | 0.00% | – |
Q3 2013 | $22,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
Q2 2013 | $22,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |